Why size matters - balancing mitochondrial dynamics in Alzheimer's disease

Trends in Neurosciences

Volumn 36, Issue 6, 2013, Pages 325-335

  DuBoff, Brian ^a   Feany, Mel ^a   Götz, Jürgen ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Actin; Amyloid (A ); Dementia; Frontotemporal dementia; Synapse; TAU

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYCLOPHILIN D; GUANOSINE TRIPHOSPHATASE; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN MITOCHONDRION; CELL DENSITY; CELL FUNCTION; DENDRITIC SPINE; DOPAMINERGIC NERVE CELL; EXCITOTOXICITY; FRONTOTEMPORAL DEMENTIA; FUSION GENE; GENE MUTATION; GENETIC ASSOCIATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MEMBRANE POTENTIAL; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL GENE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL VOLUME; NERVE DEGENERATION; NEUROTOXICITY; NITROSYLATION; NONHUMAN; PATHOGENESIS; PEROXISOME; PHENOTYPE; PRIORITY JOURNAL; RETROGRADE DEGENERATION; REVIEW; SYNAPSE; TAUOPATHY;

ADENOSINE TRIPHOSPHATE; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AXONAL TRANSPORT; CHARCOT-MARIE-TOOTH DISEASE; ENERGY METABOLISM; GTP PHOSPHOHYDROLASES; HUMANS; MEMBRANE FUSION; MEMBRANE PROTEINS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPSES; TAU PROTEINS;

EID: 84878586555     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2013.03.002     Document Type: Review

References (123)

1. Schon E.A., Przedborski S. Mitochondria: the next (neurode)generation. Neuron 2011, 70:1033-1053.
2. 2+ signaling, mitochondria and cell death. Curr. Mol. Med. 2008, 8:119-130.
3. Murphy M.P., et al. Unraveling the biological roles of reactive oxygen species. Cell Metab. 2011, 13:361-366.
4. Fischer F., et al. Mitochondrial quality control: an integrated network of pathways. Trends Biochem. Sci. 2012, 37:284-292.
5. Twig G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 2008, 27:433-446.
6. Youle R.J., van der Bliek A.M. Mitochondrial fission, fusion, and stress. Science 2012, 337:1062-1065.
7. Saxton W.M., Hollenbeck P.J. The axonal transport of mitochondria. J. Cell Sci. 2012, 125:2095-2104.
8. Ashrafi G., Schwarz T.L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013, 20:31-42.
9. Ballard C., et al. Alzheimer's disease. Lancet 2011, 377:1019-1031.
10. Ittner L.M., Götz J. Amyloid-beta and tau - a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 2011, 12:65-72.
11. Ballatore C., et al. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8:663-672.
12. Guerreiro R.J., et al. The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. Neurobiol. Aging 2012, 33:437-456.
13. Kuznetsov A.V., Margreiter R. Heterogeneity of mitochondria and mitochondrial function within cells as another level of mitochondrial complexity. Int. J. Mol. Sci. 2009, 10:1911-1929.
14. Waagepetersen H.S., et al. Cellular mitochondrial heterogeneity in cultured astrocytes as demonstrated by immunogold labeling of alpha-ketoglutarate dehydrogenase. Glia 2006, 53:225-231.
15. Vos M., et al. Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front. Synaptic Neurosci. 2010, 2:139.
16. 2+ overload than nonsynaptic mitochondria. J. Biol. Chem. 2006, 281:11658-11668.
17. Chang D.T., et al. Mitochondrial trafficking to synapses in cultured primary cortical neurons. J. Neurosci. 2006, 26:7035-7045.
18. Du H., et al. Synaptic mitochondrial pathology in Alzheimer's disease. Antioxid. Redox Signal. 2012, 16:1467-1475.
19. Naga K.K., et al. High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J. Neurosci. 2007, 27:7469-7475.
20. Renner M., et al. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 2010, 66:739-754.
21. Scheff S.W., et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68:1501-1508.
22. Borlikova G.G., et al. Alzheimer brain-derived amyloid beta-protein impairs synaptic remodeling and memory consolidation. Neurobiol. Aging 2013, 34:1315-1327.
23. Overly C.C., et al. Organelle motility and metabolism in axons vs dendrites of cultured hippocampal neurons. J. Cell Sci. 1996, 109:971-980.
24. Popov V., et al. Mitochondria form a filamentous reticular network in hippocampal dendrites but are present as discrete bodies in axons: a three-dimensional ultrastructural study. J. Comp. Neurol. 2005, 492:50-65.
25. Meeusen S., et al. Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell 2006, 127:383-395.
26. Song Z., et al. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol. Biol. Cell 2009, 20:3525-3532.
27. Tanaka A., et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191:1367-1380.
28. Leboucher G.P., et al. Stress-induced phosphorylation and proteasomal degradation of mitofusin 2 facilitates mitochondrial fragmentation and apoptosis. Mol. Cell 2012, 47:547-557.
29. Chen H., et al. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 2003, 160:189-200.
30. Alavi M.V., et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain 2007, 130:1029-1042.
31. Davies V.J., et al. Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function. Hum. Mol. Genet. 2007, 16:1307-1318.
32. Pham A.H., et al. Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum. Mol. Genet. 2012, 21:4817-4826.
33. Palmer C.S., et al. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell. Signal. 2011, 23:1534-1545.
34. Ingerman E., et al. Dnm1 forms spirals that are structurally tailored to fit mitochondria. J. Cell Biol. 2005, 170:1021-1027.
35. Palmer C.S., et al. MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep. 2011, 12:565-573.
36. DuBoff B., et al. Tau promotes neurodegeneration via DRP1 mislocalization in vivo. Neuron 2012, 75:618-632.
37. Wakabayashi J., et al. The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice. J. Cell Biol. 2009, 186:805-816.
38. Ishihara N., et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat. Cell Biol. 2009, 11:958-966.
39. Chen H., et al. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010, 141:280-289.
40. Waterham H.R., et al. A lethal defect of mitochondrial and peroxisomal fission. N. Engl. J. Med. 2007, 356:1736-1741.
41. Parone P.A., et al. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS ONE 2008, 3:e3257.
42. Chen H., Chan D.C. Mitochondrial dynamics - fusion, fission, movement, and mitophagy - in neurodegenerative diseases. Hum. Mol. Genet. 2009, 18:R169-R176.
43. Kageyama Y., et al. Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage. J. Cell Biol. 2012, 197:535-551.
44. Tondera D., et al. SLP-2 is required for stress-induced mitochondrial hyperfusion. EMBO J. 2009, 28:1589-1600.
45. Verstreken P., et al. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron 2005, 47:365-378.
46. Chen H., et al. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007, 130:548-562.
47. Anesti V., Scorrano L. The relationship between mitochondrial shape and function and the cytoskeleton. Biochim. Biophys. Acta 2006, 1757:692-699.
48. Quintero O.A., et al. Human Myo19 is a novel myosin that associates with mitochondria. Curr. Biol. 2009, 19:2008-2013.
49. Su Q., et al. Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons. Nat. Cell Biol. 2004, 6:941-953.
50. Ittner L.M., et al. Phosphorylated Tau interacts with c-Jun N-terminal kinase-interacting Protein 1 (JIP1) in Alzheimer disease. J. Biol. Chem. 2009, 284:20909-20916.
51. Misko A., et al. Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex. J. Neurosci. 2010, 30:4232-4240.
52. Guo X., et al. The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 2005, 47:379-393.
53. Frederick R.L., et al. Yeast Miro GTPase, Gem1p, regulates mitochondrial morphology via a novel pathway. J. Cell Biol. 2004, 167:87-98.
54. Varadi A., et al. Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J. Cell Sci. 2004, 117:4389-4400.
55. 2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20728-20733.
56. MacAskill A.F., et al. GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons. Mol. Cell. Neurosci. 2009, 40:301-312.
57. 2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell 2009, 136:163-174.
58. Stagi M., et al. Unloading kinesin transported cargoes from the tubulin track via the inflammatory c-Jun N-terminal kinase pathway. FASEB J. 2006, 20:2573-2575.
59. Figge M.T., et al. Deceleration of fusion-fission cycles improves mitochondrial quality control during aging. PLoS Comput. Biol. 2012, 8:e1002576.
60. Kowald A., Kirkwood T.B. Evolution of the mitochondrial fusion-fission cycle and its role in aging. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:10237-10242.
61. Berman S.B., et al. Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J. Cell Biol. 2009, 184:707-719.
62. Arnold B., et al. Integrating multiple aspects of mitochondrial dynamics in neurons: age-related differences and dynamic changes in a chronic rotenone model. Neurobiol. Dis. 2011, 41:189-200.
63. Blass J.P., Gibson G.E. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol. (Paris) 1991, 147:513-525.
64. Wong-Riley M., et al. Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res. 1997, 37:3593-3608.
65. Ghosh S.S., et al. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ann N. Y. Acad. Sci. 1999, 893:176-191.
66. Hirai K., et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 2001, 21:3017-3023.
67. Perez-Gracia E., et al. Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase. Acta Neuropathol. 2008, 116:261-268.
68. Bosetti F., et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol. Aging 2002, 23:371-376.
69. Wang X., et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci. 2009, 29:9090-9103.
70. Manczak M., et al. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet. 2011, 20:2495-2509.
71. Wang X., et al. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am. J. Pathol. 2008, 173:470-482.
72. Cho D.H., et al. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
73. Bossy B., et al. S-Nitrosylation of DRP1 does not affect enzymatic activity and is not specific to Alzheimer's disease. J. Alzheimers Dis. 2010, 20(Suppl. 2):S513-S526.
74. Lustbader J.W., et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004, 304:448-452.
75. Pagani L., Eckert A. Amyloid-beta interaction with mitochondria. Int. J. Alzheimer's Dis. 2011, 2011:925050.
76. Fein J.A., et al. Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes. Am. J. Pathol. 2008, 172:1683-1692.
77. Winton M.J., et al. Intraneuronal APP, not free Aβ peptides in 3×Tg-AD mice: implications for Tau versus Aβ-mediated Alzheimer neurodegeneration. J. Neurosci. 2011, 31:7691-7699.
78. Hammond M., et al. Profiling cellular protein complexes by proximity ligation with dual tag microarray readout. PLoS ONE 2012, 7:e40405.
79. Campello S., et al. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J. Exp. Med. 2006, 203:2879-2886.
80. Pigino G., et al. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5907-5912.
81. Wang X., et al. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener. Dis. 2010, 7:56-59.
82. Du H., et al. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18670-18675.
83. Caspersen C., et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J. 2005, 19:2040-2041.
84. Trushina E., et al. Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS ONE 2012, 7:e32737.
85. Calkins M.J., Reddy P.H. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons. Biochim. Biophys. Acta 2011, 1812:507-513.
86. Wang X., et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19318-19323.
87. Calkins M.J., et al. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 2011, 20:4515-4529.
88. Calkins M.J., Reddy P.H. Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage. Biochim. Biophys. Acta 2011, 1812:1182-1189.
89. Schmitt K., et al. Insights into mitochondrial dysfunction: aging, amyloid-beta, and tau-A deleterious trio. Antioxid. Redox Signal. 2012, 16:1456-1466.
90. Rhein V., et al. Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20057-20062.
91. Lim Y-A., et al. Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 2010, 10:1621-1633.
92. Khurana V., et al. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 2010, 6:e1001026.
93. Quintanilla R.A., et al. Truncated tau and Abeta cooperatively impair mitochondria in primary neurons. Neurobiol. Aging 2012, 33:e25-e35.
94. Quintanilla R.A., et al. Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease. J. Biol. Chem. 2009, 284:18754-18766.
95. Schulz K.L., et al. A new link to mitochondrial impairment in tauopathies. Mol. Neurobiol. 2012, 46:205-216.
96. Kopeikina K.J., et al. Tau accumulation causes mitochondrial distribution deficits in neurons in a mouse model of tauopathy and in human Alzheimer's disease brain. Am. J. Pathol. 2011, 179:2071-2082.
97. Shahpasand K., et al. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer's disease. J. Neurosci. 2012, 32:2430-2441.
98. Davis R.C., et al. Amyloid beta dimers/trimers potently induce cofilin-actin rods that are inhibited by maintaining cofilin-phosphorylation. Mol. Neurodegener. 2011, 6:10.
99. Fulga T.A., et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat. Cell Biol. 2007, 9:139-148.
100. Korobova F., et al. An actin-dependent step in mitochondrial fission mediated by the ER-associated formin INF2. Science 2013, 339:464-467.
101. Wu H.Y., et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J. Neurosci. 2010, 30:2636-2649.
102. Nakamura T., Lipton S.A. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases. Cell Death Differ. 2011, 18:1478-1486.
103. Ittner L.M., et al. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:15997-16002.
104. Hirano A. Hirano bodies and related neuronal inclusions. Neuropathol. Appl. Neurobiol. 1994, 20:3-11.
105. Ittner L.M., et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
106. Zhou L., et al. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. Nat. Med. 2010, 16:1439-1443.
107. Zuchner S., et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 2004, 36:449-451.
108. Alexander C., et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26:211-215.
109. Delettre C., et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 2000, 26:207-210.
110. Kitada T., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
111. Valente E.M., et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 304:1158-1160.
112. McManus M.J., et al. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 2011, 31:15703-15715.
113. Reddy P.H., et al. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim. Biophys. Acta 2012, 1822:639-649.
114. Durazo S.A., Kompella U.B. Functionalized nanosystems for targeted mitochondrial delivery. Mitochondrion 2012, 12:190-201.
115. Yao J., et al. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease. J. Neurosci. 2011, 31:2313-2320.
116. Lim Y.A., et al. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-beta-mediated deregulation of estradiol. PLoS ONE 2011, 6:e28887.
117. Tachibana M., et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009, 461:367-372.
118. 2-DNA oligonucleotide nanoconjugates directed to nucleolus and mitochondria indicates sequence specificity. Nano Lett. 2007, 7:596-601.
119. Lim K.L., et al. Mitochondrial dynamics and Parkinson's disease: focus on parkin. Antioxid. Redox Signal. 2012, 16:935-949.
120. Chang D.T., et al. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol. Dis. 2006, 22:388-400.
121. Song W., et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 2011, 17:377-382.
122. Martin L.J. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2006, 65:1103-1110.
123. Magrane J., et al. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J. Neurosci. 2012, 32:229-242.